Hüfner Katharina, Tymoszuk Piotr, Ausserhofer Dietmar, Sahanic Sabina, Pizzini Alex, Rass Verena, Galffy Matyas, Böhm Anna, Kurz Katharina, Sonnweber Thomas, Tancevski Ivan, Kiechl Stefan, Huber Andreas, Plagg Barbara, Wiedermann Christian J, Bellmann-Weiler Rosa, Bachler Herbert, Weiss Günter, Piccoliori Giuliano, Helbok Raimund, Loeffler-Ragg Judith, Sperner-Unterweger Barbara
Department of Psychiatry, Psychotherapy, Psychosomatics and Medical Psychology, University Hospital for Psychiatry II, Medical University of Innsbruck, Innsbruck, Austria.
Data Analytics as a Service Tirol, Innsbruck, Austria.
Front Med (Lausanne). 2022 Mar 14;9:792881. doi: 10.3389/fmed.2022.792881. eCollection 2022.
Coronavirus Disease-19 (COVID-19) convalescents are at risk of developing a mental health disorder or worsening of a pre-existing one. COVID-19 outpatients have been less well characterized than their hospitalized counterparts. The objectives of our study were to identify indicators for poor mental health following COVID-19 outpatient management and to identify high-risk individuals.
We conducted a binational online survey study with adult non-hospitalized COVID-19 convalescents (Austria/AT: = 1,157, Italy/IT: = 893). Primary endpoints were positive screening for depression and anxiety (Patient Health Questionnaire; PHQ-4) and self-perceived overall mental health (OMH) and quality of life (QoL) rated with 4 point Likert scales. Psychosocial stress was surveyed with a modified PHQ stress module. Associations of the mental health and QoL with socio-demographic, COVID-19 course, and recovery variables were assessed by multi-parameter Random Forest and Poisson modeling. Mental health risk subsets were defined by self-organizing maps (SOMs) and hierarchical clustering algorithms. The survey analyses are publicly available (https://im2-ibk.shinyapps.io/mental_health_dashboard/).
Depression and/or anxiety before infection was reported by 4.6% (IT)/6% (AT) of participants. At a median of 79 days (AT)/96 days (IT) post-COVID-19 onset, 12.4% (AT)/19.3% (IT) of subjects were screened positive for anxiety and 17.3% (AT)/23.2% (IT) for depression. Over one-fifth of the respondents rated their OMH (AT: 21.8%, IT: 24.1%) or QoL (AT: 20.3%, IT: 25.9%) as fair or poor. Psychosocial stress, physical performance loss, high numbers of acute and sub-acute COVID-19 complaints, and the presence of acute and sub-acute neurocognitive symptoms (impaired concentration, confusion, and forgetfulness) were the strongest correlates of deteriorating mental health and poor QoL. In clustering analysis, these variables defined subsets with a particularly high propensity of post-COVID-19 mental health impairment and decreased QoL. Pre-existing depression or anxiety (DA) was associated with an increased symptom burden during acute COVID-19 and recovery.
Our study revealed a bidirectional relationship between COVID-19 symptoms and mental health. We put forward specific acute symptoms of the disease as "red flags" of mental health deterioration, which should prompt general practitioners to identify non-hospitalized COVID-19 patients who may benefit from early psychological and psychiatric intervention.
[ClinicalTrials.gov], identifier [NCT04661462].
新型冠状病毒肺炎(COVID-19)康复者有患心理健康障碍或使原有心理健康障碍恶化的风险。与住院的COVID-19患者相比,门诊患者的特征描述较少。我们研究的目的是确定COVID-19门诊治疗后心理健康不佳的指标,并识别高危个体。
我们对非住院的成年COVID-19康复者进行了一项双边在线调查研究(奥地利/AT:n = 1157,意大利/IT:n = 893)。主要终点是抑郁和焦虑的阳性筛查(患者健康问卷;PHQ-4)以及用4点李克特量表评定的自我感知总体心理健康(OMH)和生活质量(QoL)。用改良的PHQ应激模块对心理社会应激进行调查。通过多参数随机森林和泊松模型评估心理健康和生活质量与社会人口统计学、COVID-19病程及康复变量之间的关联。通过自组织映射(SOM)和层次聚类算法定义心理健康风险子集。调查分析结果可公开获取(https://im2-ibk.shinyapps.io/mental_health_dashboard/)。
4.6%(意大利)/6%(奥地利)的参与者报告感染前有抑郁和/或焦虑。在COVID-19发病后的中位数79天(奥地利)/96天(意大利),12.4%(奥地利)/19.3%(意大利)的受试者焦虑筛查呈阳性,17.3%(奥地利)/23.2%(意大利)的受试者抑郁筛查呈阳性。超过五分之一的受访者将他们的总体心理健康(奥地利:21.8%,意大利:24.1%)或生活质量(奥地利:20.3%,意大利:25.9%)评为一般或较差。心理社会应激、身体机能丧失、大量急性和亚急性COVID-19症状以及急性和亚急性神经认知症状(注意力不集中、意识模糊和健忘)的出现是心理健康恶化和生活质量差的最强相关因素。在聚类分析中,这些变量定义了COVID-19后心理健康受损和生活质量下降倾向特别高的子集。既往存在的抑郁或焦虑(DA)与急性COVID-19及康复期间症状负担增加有关。
我们的研究揭示了COVID-19症状与心理健康之间的双向关系。我们提出该疾病的特定急性症状是心理健康恶化的“红旗”,这应促使全科医生识别可能从早期心理和精神干预中受益的非住院COVID-19患者。
[ClinicalTrials.gov],标识符[NCT04661462]